AIM News and Press, AIM ImmunoTech Inc. From 08/24/23

BROOKLYN, N.Y., Aug. 24, 2023 (GLOBE NEWSWIRE) -- AI-Media , a leading provider of captioning technology and infrastructure, is proud to unveil its groundbreaking AI-Powered LEXI Captioning Tool Kit . This comprehensive collection of automated captioning solutions marks a new era in the i...

Group Seeking to Take Control of 75% of AIM Board Failed to Properly Disclose Myriad Interconnections, Understandings and Arrangements Among Its Members – Violating the Company’s Bylaws and Preventing Shareholders from Being Able to Make Fully Informed Decisions Group’...

2023-08-15 10:59:06 ET AIM ImmunoTech Inc. (AIM) Q2 2023 Earnings Conference Call August 15, 2023, 8:30 AM ET Company Participants Thomas Equels - Executive Vice Chairman, Chief Executive Officer and President Christopher McAleer - Scientific Officer Conference...

– Continued operational execution across pipeline towards multiple clinical and regulatory value-driving milestones expected in the second half of 2023 – Company to host conference call and webcast today at 8:30 AM ET OCALA, Fla., Aug. 15, 2023 (GLOBE NEWSWIRE) -- ...

2023-08-15 06:10:05 ET AIM ImmunoTech press release ( NYSE: AIM ): Q2 GAAP EPS of -$0.10 beats by $0.01 . Revenue of $0.04M (+33.3% Y/Y) beats by $0.02M . For further details see: AIM ImmunoTech GAAP EPS of -$0.10 beats by $0.01, revenue of $0.04M beats b...

2023-08-14 14:27:27 ET AIM ImmunoTech ( NYSE: AIM ) is scheduled to announce Q2 earnings results on Tuesday, August 15th, before market open. The consensus EPS Estimate is -$0.10 and the consensus Revenue Estimate is $0.02M For further details see: AIM ImmunoTech...

2023-08-14 10:17:31 ET Major earnings expected before the bell on Tuesday include: Cardinal Health ( CAH ) The Home Depot ( HD ) Jumia Technologies ( JMIA ) Seadrill ( SDRL ) Sea ( SE ) For further details see: Notable earnings before Tues...

OCALA, Fla., Aug. 09, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) announced today that management will host a conference call and webcast to discuss the Company’s Q2 2023 operational and financial results on...

OCALA, Fla., Aug. 08, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM”) today announced the completion of enrollment in the company’s Phase 2 study evaluating Ampligen® as a potential therapeutic for people with post-COVID conditions (“...

BROOKLYN, N.Y., July 19, 2023 (GLOBE NEWSWIRE) -- Ai-Media , the industry leader in technology-driven live captioning, transcription, and translation solutions, is delighted to unveil the ground-breaking LEXI Viewer . This innovative solution revolutionizes how event organizers captivate ...